• Login
    Search 
    •   SUNScholar
    • University Centres and Units
    • Search
    •   SUNScholar
    • University Centres and Units
    • Search
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-3 of 3

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study 

    Janssen J.P.; Collier G.; Astoul P.; Tassi G.F.; Noppen M.; Rodriguez-Panadero F.; Loddenkemper R.; Herth F.J.; Gasparini S.; Marquette C.H.; Becke B.; Froudarakis M.E.; Driesen P.; Bolliger C.T.; Tschopp J.-M. (2007)
    Background: Talc is the most effective chemical pleurodesis agent for patients with malignant pleural effusion. However, concerns have arisen about the safety of intrapleural application of talc, after reports of development ...
    Thumbnail

    Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia 

    Kastelein J.J.P.; Van Leuven S.I.; Burgess L.; Evans G.W.; Kuivenhoven J.A.; Barter P.J.; Revkin J.H.; Grobbee D.E.; Riley W.A.; Shear C.L.; Duggan W.T.; Bots M.L. (2007)
    Background: Torcetrapib, an inhibitor of cholesteryl ester transfer protein, may reduce atherosclerotic vascular disease by increasing levels of high-density lipoprotein (HDL) cholesterol. Methods: A total of 850 patients ...
    Thumbnail

    Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study 

    Davidson M.; Emsley R.; Kramer M.; Ford L.; Pan G.; Lim P.; Eerdekens M. (2007)
    Background: Paliperidone extended-release tablet (paliperidone ER) is an oral psychotropic agent developed for schizophrenia treatment. Paliperidone (9-OH-risperidone, metabolite of risperidone), when used with OROS ...

    Browse

    All of SUNScholarCommunities & CollectionsBy TitleBy AuthorBy AdvisorBy DateBy SubjectBy TypeThis CommunityBy TitleBy AuthorBy AdvisorBy DateBy SubjectBy Type

    My Account

    LoginRegister

    Discover

    AuthorAstoul P. (1)Barter P.J. (1)Becke B. (1)Bolliger C.T. (1)Bots M.L. (1)Burgess L. (1)Collier G. (1)Davidson M. (1)Driesen P. (1)Duggan W.T. (1)... View MoreSubjectAdult (3)adult (3)
    article (3)
    clinical trial (3)
    controlled clinical trial (3)
    controlled study (3)
    Female (3)
    female (3)
    human (3)
    Humans (3)... View MoreDate Issued
    2007 (3)
    Has File(s)
    No (3)
    Copyright © Stellenbosch University | ISSN-L 2310-7855
    Contact Us